Please login to the form below

Not currently logged in
Email:
Password:

bmore creative hires Kush Rach as new business director

Independent agency appoints former Pulsar Healthcare business development director

Kush Rach bmore creativeUK-based multichannel agency bmore creative has appointed Kush Rach as its new business director.

Rach previously spent nearly three years with Pulsar Healthcare as its business development director and prior to that served industry-side at Novartis.

He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2 diabetes.

Ben Blackmore, bmore creative's MD, told The Directory: "We are delighted to welcome Kush into our growing team here at bmore creative. Kush went through a very competitive and difficult recruitment process to become our new business director here.

“His excellent industry knowledge and dynamic personality are just two of the reasons he was selected over and above the other candidates."

Before his time at Novartis, Rach was business development manager at the pre- and post-launch medical communications agency Zaicom MMC, where he worked on global communications projects for GSK Bio, Ferring and Lundbeck.

Having gained his degree in pharmacology at University of Aberdeen, Rach initially joined Altana Pharma as a medical representative before becoming a key account manager at Teva and business development manager at Charles River Laboratories, where he worked on clinical trial programmes for Ferring, Genmab, AstraZeneca, and Aerocrine (spending much of his time in Scandinavia).

20th March 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics